Liquidia Technologies, Inc.
(NASDAQ : LQDA)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-0.34%139.610.7%$1068.84m
PFEPfizer Inc.
-0.26%42.650.9%$908.26m
MRKMerck & Co., Inc.
0.21%82.950.6%$729.76m
BMYBristol-Myers Squibb Company
1.59%48.321.4%$540.25m
LLYEli Lilly and Company
0.63%112.441.0%$476.60m
ABBVAbbVie, Inc.
0.19%78.842.2%$357.02m
NVSNovartis AG Sponsored ADR
0.28%89.770.2%$198.55m
AZNAstraZeneca PLC Sponsored ADR
0.62%39.921.2%$112.03m
GSKGlaxoSmithKline plc Sponsored ADR
-0.29%40.000.2%$88.88m
NVONovo Nordisk A/S Sponsored ADR Class B
0.74%51.340.1%$74.07m
SNYSanofi Sponsored ADR
0.21%42.560.2%$73.29m
LCILannett Company, Inc.
3.31%5.3936.6%$4.87m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.78%2.201.6%$0.36m
EPIXESSA Pharma Inc
0.88%2.300.1%$0.02m

Company Profile

Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded in 2004 and is headquartered in Durham, NC.